Evidence map›Paper›PMID 39048820›Full record

ArticleNature2024

Blood culture-free ultra-rapid antimicrobial susceptibility testing.

Tae Hyun Kim, Junwon Kang, Haewook Jang, Hyelyn Joo, Gi Yoon Lee, Hamin Kim, Untack Cho, Hyeeun Bang, Jisung Jang, Sangkwon Han and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tae Hyun Kim *Bio-MAX Institute, Seoul National University, Seoul, Korea.
Junwon Kang *Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Korea.
Haewook Jang *Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Korea.
Hyelyn JooInterdisciplinary Program in Bioengineering, Seoul National University, Seoul, Korea.
Gi Yoon LeeDepartment of Electrical and Computer Engineering, Seoul National University, Seoul, Korea.
Hamin KimInterdisciplinary Program in Bioengineering, Seoul National University, Seoul, Korea.
Untack ChoQuantaMatrix Inc., Seoul, Korea.
Hyeeun BangQuantaMatrix Inc., Seoul, Korea.
Jisung JangQuantaMatrix Inc., Seoul, Korea.
Sangkwon HanQuantaMatrix Inc., Seoul, Korea.
Dong Young KimQuantaMatrix Inc., Seoul, Korea.ORCID 0000-0002-2746-0790
Chan Mi LeeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-7907-0412
Chang Kyung KangDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Pyoeng Gyun ChoeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-6794-7918
Nam Joong KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-6793-9467
Myoung-Don OhDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-2344-7695
Taek Soo KimDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-2093-1721
Inho KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ihkimmd@snu.ac.kr.ORCID 0000-0002-8785-6201
Wan Beom ParkDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. wbpark1@snu.ac.kr.ORCID 0000-0003-0022-9625
Sunghoon KwonBio-MAX Institute, Seoul National University, Seoul, Korea. skwon@snu.ac.kr.ORCID 0000-0003-3514-1738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment assessment and patient outcome for sepsis depend predominantly on the timely administration of appropriate antibiotics

Indexed as

Anti-Bacterial AgentsBacteriaMicrobial Sensitivity TestsMicrochip Analytical ProceduresSepsisbeta 2-Glycoprotein IBlood CultureHumansRetrospective StudiesTime FactorsAnti-Bacterial Agentsbeta 2-Glycoprotein I

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.